ACTOS (Pioglitazone) ( DrugBank: Pioglitazone )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
13	多発性硬化症／視神経脊髄炎	1

13. 多発性硬化症／視神経脊髄炎

臨床試験数 : 3,342 / 薬物数 : 2,355 - (DrugBank : 406) / 標的遺伝子数 : 269 - 標的パスウェイ数 : 241

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00242177 (ClinicalTrials.gov)	October 2003	18/10/2005	Pilot Test of ACTOS in Multiple Sclerosis: Safety and Tolerability	Pilot Test of ACTOS in Multiple Sclerosis: Safety and Tolerability	Multiple Sclerosis, Relapsing-Remitting	Drug: ACTOS (Pioglitazone)	University of Illinois at Chicago	Takeda Pharmaceuticals North America, Inc.	Completed	18 Years	65 Years	All	30	Phase 1	United States

First Previous1Next Last